Hydrochlorothiazide Use in Hypertensive Patients with BPH
Safety Profile in BPH
- Thiazide diuretics, including hydrochlorothiazide, do not adversely affect lower urinary tract symptoms or urinary flow rates in men with BPH, as they work by reducing sodium reabsorption in the distal tubule and do not interact with alpha-adrenergic receptors that control bladder neck and prostatic smooth muscle tone 1, 2
Optimal Diuretic Selection
- The American Heart Association guidelines identify chlorthalidone as a thiazide-like diuretic with strong evidence for reducing cardiovascular outcomes, providing 7-8 mmHg greater systolic blood pressure reduction compared to equivalent doses of hydrochlorothiazide 3
- Consider switching from hydrochlorothiazide to chlorthalidone for superior blood pressure control and cardiovascular outcomes, as recommended by the American Heart Association 3
Combination Therapy Considerations
- If blood pressure remains uncontrolled on hydrochlorothiazide alone, add a calcium channel blocker (amlodipine 5-10 mg) or ARB rather than switching to alpha-blockers, as the preferred triple therapy combination for resistant hypertension is ARB + thiazide diuretic + dihydropyridine calcium channel blocker 4, 5
- Alpha-blockers like doxazosin can treat both hypertension and BPH simultaneously but should be avoided as first-line antihypertensive therapy due to inferior cardiovascular outcomes, and should only be used if other antihypertensive medications at maximum tolerated doses fail to achieve blood pressure control 7
Monitoring Requirements
- Recheck blood pressure within 2-4 weeks after initiating or adjusting diuretic therapy, and monitor serum electrolytes (potassium, sodium) and renal function (creatinine, eGFR) within 2-4 weeks of starting thiazide diuretics 4